SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc

<< Previous

Bullboard Posts

Next >>

Post by FactFinder1994on Jun 28, 2021 1:24pm

240 Views

Post# 33460207

The story should be shared....

Shareprice was in the mid 30's in early April when RALI-Dx was subitted, and again as grant was received in mid-April. With pending news from FDA, and additional FDA submissions due out very soon as well, why not share the story?

2021-04-13 15:14	C:SQD	SQI Diagnostics Inc	0.35	News Release	SQI receives $900,000 grant for infection tech R&D
2021-04-01 09:43	C:SQD	SQI Diagnostics Inc	0.34	News Release	SQI submits RALI-Dx for emergency-use authorization